
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing - 2
Will Comet C/2025 R3 (PanSTARRS) be the 'great comet' of 2026? - 3
My Enterprising Excursion: Building a Startup - 4
Thousands of Walgreens nasal spray bottles recalled. See which ones. - 5
Islamic State group militants claim capture and execution of a Nigerian brigadier general
Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
Find Your Ideal Tea: Six Particular Assortments
Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw
UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
12 times rockets and spacecraft crashed and burned in 2025
UAE recalls some Nestle infant formula products, Qatar warns consumers
How comfort foods trigger pleasure in our brains
Former 'Bachelorette' welcomes 1st baby via emergency c-section












